• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Localized and systemic approaches to treating hepatocellular carcinoma.

作者信息

Knox Jennifer J, Cleary Sean P, Dawson Laura A

机构信息

All authors: University of Toronto, Princess Margaret Cancer Centre, Toronto, ON, Canada.

出版信息

J Clin Oncol. 2015 Jun 1;33(16):1835-44. doi: 10.1200/JCO.2014.60.1153. Epub 2015 Apr 27.

DOI:10.1200/JCO.2014.60.1153
PMID:25918289
Abstract
摘要

相似文献

1
Localized and systemic approaches to treating hepatocellular carcinoma.治疗肝细胞癌的局部和全身方法。
J Clin Oncol. 2015 Jun 1;33(16):1835-44. doi: 10.1200/JCO.2014.60.1153. Epub 2015 Apr 27.
2
Treatment of hepatocellular carcinoma.肝细胞癌的治疗。
Oncology. 2009;77 Suppl 1:43-9. doi: 10.1159/000258495. Epub 2010 Feb 2.
3
Emerging approaches in the management of patients with neuroendocrine liver metastasis: role of liver-directed and systemic therapies.神经内分泌肝脏转移患者管理的新方法：肝定向和系统治疗的作用。
J Am Coll Surg. 2013 Jan;216(1):123-34. doi: 10.1016/j.jamcollsurg.2012.08.027. Epub 2012 Oct 11.
4
Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.局部三维适形放疗联合经动脉化疗栓塞治疗Ⅲ期肝细胞癌患者的研究
Am J Clin Oncol. 2003 Aug;26(4):e92-9. doi: 10.1097/01.COC.0000077936.97997.AB.
5
Comparison of resection, liver transplantation and transcatheter oily chemoembolisation in the treatment of hepatocellular carcinoma.肝细胞癌治疗中切除术、肝移植术与经导管油性化疗栓塞术的比较
Wiad Lek. 1997;50 Suppl 1 Pt 1:413-5.
6
Multimodality treatment involving radiotherapy for advanced liver-confined hepatocellular carcinoma.多模态治疗包括放疗治疗局限性晚期肝癌。
Oncology. 2014;87 Suppl 1:90-8. doi: 10.1159/000368151. Epub 2014 Nov 22.
7
Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies.使用化疗栓塞联合其他疗法治疗肝细胞癌的疗效
Cancer Treat Rev. 2006 Dec;32(8):594-606. doi: 10.1016/j.ctrv.2006.08.002. Epub 2006 Oct 11.
8
Clinical outcome of 251 patients with extrahepatic metastasis at initial diagnosis of hepatocellular carcinoma: does transarterial chemoembolization improve survival in these patients?251 例原发性肝细胞癌肝外转移患者的临床转归：经动脉化疗栓塞术是否能改善这些患者的生存？
J Gastroenterol Hepatol. 2011 Jan;26(1):145-54. doi: 10.1111/j.1440-1746.2010.06341.x.
9
Classification and staging of hepatocellular carcinoma: an aid to clinical decision-making.肝细胞癌的分类和分期：辅助临床决策。
Clin Liver Dis. 2015 May;19(2):277-94. doi: 10.1016/j.cld.2015.01.011.
10
Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009.亚洲肝细胞癌的管理：2009年亚洲肿瘤学峰会共识声明
Lancet Oncol. 2009 Nov;10(11):1111-8. doi: 10.1016/S1470-2045(09)70241-4.

引用本文的文献

1
α-Fetoprotein model versus Milan criteria in predicting outcomes after hepatic resection for hepatocellular carcinoma: multicentre study.甲胎蛋白模型与米兰标准在预测肝细胞癌肝切除术后结局中的比较：多中心研究
BJS Open. 2025 Mar 4;9(2). doi: 10.1093/bjsopen/zraf041.
2
Preclinical evaluation of radiolabeled tissue factor-targeted peptide for theranostics of hepatocellular carcinoma post percutaneous ethanol injection.放射性标记的组织因子靶向肽用于经皮乙醇注射后肝细胞癌诊疗的临床前评估
Theranostics. 2024 Oct 28;14(19):7370-7382. doi: 10.7150/thno.102130. eCollection 2024.
3
Non-Coding RNAs as Potential Diagnostic/Prognostic Markers for Hepatocellular Carcinoma.
非编码 RNA 作为肝细胞癌的潜在诊断/预后标志物。
Int J Mol Sci. 2024 Nov 14;25(22):12235. doi: 10.3390/ijms252212235.
4
Safflower Yellow Inhibits Progression of Hepatocellular Carcinoma by Modulating Immunological Tolerance via FAK Pathway.红花黄色素通过 FAK 通路调控免疫耐受抑制肝癌进展。
Chin J Integr Med. 2024 Apr;30(4):339-347. doi: 10.1007/s11655-023-3705-1. Epub 2023 Nov 9.
5
Impact of sarcopenia on outcomes of patients undergoing liver resection for hepatocellular carcinoma.肌肉减少症对肝细胞癌患者行肝切除术治疗结局的影响。
J Cachexia Sarcopenia Muscle. 2022 Oct;13(5):2383-2392. doi: 10.1002/jcsm.13040. Epub 2022 Jul 19.
6
Radiologic Response as a Prognostic Factor in Advanced Hepatocellular Carcinoma with Macroscopic Vascular Invasion after Transarterial Chemoembolization and Radiotherapy.放射学反应作为经动脉化疗栓塞和放疗后伴有宏观血管侵犯的晚期肝细胞癌的预后因素
Liver Cancer. 2021 Dec 7;11(2):152-161. doi: 10.1159/000521227. eCollection 2022 Apr.
7
Janus nanocarriers for magnetically targeted and hyperthermia-enhanced curcumin therapy of liver cancer.用于肝癌磁靶向和热疗增强姜黄素治疗的Janus纳米载体
RSC Adv. 2018 Aug 29;8(53):30448-30454. doi: 10.1039/c8ra05694c. eCollection 2018 Aug 24.
8
TILA-TACE - an approach for effective local control of hepatocellular carcinoma.经动脉化疗栓塞联合肿瘤内局部注射碘油乙醇乳剂（TILA-TACE）——一种有效局部控制肝细胞癌的方法
J Interv Med. 2019 Apr 30;1(1):58-63. doi: 10.19779/j.cnki.2096-3602.2018.01.11. eCollection 2018 Feb.
9
Regorafenib combined with transarterial chemoembolization for unresectable hepatocellular carcinoma: a real-world study.瑞戈非尼联合肝动脉化疗栓塞治疗不可切除肝细胞癌的真实世界研究。
BMC Gastroenterol. 2021 Oct 20;21(1):393. doi: 10.1186/s12876-021-01967-3.
10
Molecular classification of hepatocellular carcinoma: prognostic importance and clinical applications.肝细胞癌的分子分型：预后意义与临床应用。
J Cancer Res Clin Oncol. 2022 Jan;148(1):15-29. doi: 10.1007/s00432-021-03826-w. Epub 2021 Oct 8.